Literature DB >> 18571091

Successful treatment of pseudophakic cystoid macular edema with intravitreal bevacizumab.

Antonio Barone1, Francesco Prascina, Vincenzo Russo, Cristiana Iaculli, Vito Primavera, Giuseppe Querques, Andrea Stella, Nicola Delle Noci.   

Abstract

A 67-year-old woman developed refractory pseudophakic cystoid macular edema (CME) after uneventful phacoemulsification. Three months after an intravitreal injection of bevacizumab (1.25 mg), the CME was completely resolved, with resultant improvement in visual acuity.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18571091     DOI： 10.1016/j.jcrs.2008.02.037

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN： 0886-3350            Impact factor:   3.351


  3 in total

1.  Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema.

Authors:  Ayse Gul Kocak Altintas; Cagri Ilhan
Journal:  Korean J Ophthalmol       Date:  2019-06

2.  Perioperative Management of Uveitic Cataracts.

Authors:  Judy L Chen; Pooja Bhat; Ann-Marie Lobo-Chan
Journal:  Adv Ophthalmol Optom       Date:  2019-05-18

3.  Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review.

Authors:  Khalil Ghasemi Falavarjani; Mohammad-Mehdi Parvaresh; Mehdi Modarres; Masih Hashemi; Nasrollah Samiy
Journal:  J Ophthalmic Vis Res       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.